Adimmune Corp (4142) — Cash Flow Reinvestment Rate
Adimmune Corp (4142) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting NT$62.47 Million (capex NT$42.60 Million plus investments NT$19.87 Million) from operating cash flow of NT$658.32 Million. Check 4142 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Adimmune Corp Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Adimmune Corp across 6 annual periods. Explore Adimmune Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Adimmune Corp (2007–2024)
Year-by-year capital reinvestment analysis for Adimmune Corp. For live market cap and broader valuation context, see Adimmune Corp market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | NT$256.18 Million | NT$668.48 Million | NT$155.22 Million | ▲ +72.2% |
| 2020 | 0.22x | NT$516.76 Million | NT$2.32 Billion | NT$218.30 Million | ▼ -99.6% |
| 2017 | 61.73x | NT$424.37 Million | NT$6.87 Million | NT$11.35 Million | ▲ +4990.1% |
| 2010 | 1.21x | NT$626.30 Million | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$703.82 Million | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$265.77 Million | NT$31.26 Million | NT$265.77 Million | — |